Close Menu

NEW YORK (GenomeWeb) – Diagnostics developer HealthTell announced today that it has completed a $26 million Series B financing round led by Third Point Ventures.

The company, which also raised $14 million in a previous Series A round, plans to use the proceeds to commercialize panels for tests for autoimmune diseases, such as lupus.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.